Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Striyker who wrote (1999)	6/28/1998 6:06:00 PM
From: drdan	Read Replies (1) \| Respond to of 5402

No, it was not a dumb question; as a matter af fact, it's a great idea in theory but in reality no one privy to any info about buying or bankrolling Sanguine would divulge anything directly lest they lose their job for divulging info on strategi‡ moves to come . You might call the IR of a company like Johnson& Johnson, Eli Lilly, or Baxter, or talk to someone in their Research and Development depts. who might intimate what is going on with potential future allliances and buy-ins....you might get a hint from someone...or, if you know investment people in biotech, see if they can snoop around....these ideas can be tried by anyone....by the way, Forthright is a biotech finance person......maybe he can use his contacts to find something out about Sanguine.... Striyker, I thought that I had responded to you earlier, but maybe the message did not get thru.I am sorry.Remember, no question is dumb other than the one that you do not ask......none of us are all-knowing...have a good one........drdan